| Log in

IFC To Invest Rs 64 Crore In Pharma Contract Manufacturer Hikal

17 August, 2008

International Finance Corporation (IFC), the private equity arm of the World Bank, has agreed to invest Rs 64.46 crore in contract pharmaceutical manufacturing company Hikal Ltd. The company’s board has approved issuing 1.36 million shares to the World Bank arm on a preferential basis. This translates into an 8.2 per cent stake in the company.

“The capital inflows will be used for capacity expansion across Hikal’s manufacturing and research facilities,” said Jai Hiremath, Hikal’s Vice-Chairman & Managing Director. The expansions will be carried out at Hikal’s existing sites at Jigani (near Bangalore), Panoli (Gujarat) and Taloja (near Mumbai).

Earlier this week, Hikal announced the inauguration of a new multipurpose agrochemical plant at Taloja for the supply of Active Ingredients for Crop Protection Products to Bayer CropScience AG. The company which manufactures active pharmaceutical ingredients (API) for the pharmaceutical industry as well as technicals for the agrochemical industry has embarked on a capital expenditure plan to enhance capacities for existing products and to set up capacities for new planned products.

 


Leave Your Comment
IFC to lend up to $8M to Hikal

IFC to lend up to $8M to Hikal

Bhawna Gupta 5 years ago
International Finance Corporation (IFC), the private sector investment arm of...
IFC to make $47.5 mn debt investment in Granules India

IFC to make $47.5 mn debt investment in Granules India

TEAM VCC 10 months ago
International Finance Corporation, the private-sector arm of the World Bank, is...
IFC lending $147.5M to Jubilant Pharma

IFC lending $147.5M to Jubilant Pharma

Shruti Ambavat 4 years ago
International Finance Corporation (IFC), a member of the World Bank Group, is...
No Comments

IFC To Invest Rs 64 Crore In Pharma Contract Manufacturer Hikal

Powered by WordPress.com VIP